Mutational and clinical spectrum of Japanese patients with hereditary hemorrhagic telangiectasia
- PMID: 34872578
- PMCID: PMC8647423
- DOI: 10.1186/s12920-021-01139-y
Mutational and clinical spectrum of Japanese patients with hereditary hemorrhagic telangiectasia
Abstract
Background: Hereditary hemorrhagic telangiectasia (HHT) is a dominantly inherited vascular disorder characterized by recurrent epistaxis, skin/mucocutaneous telangiectasia, and organ/visceral arteriovenous malformations (AVM). HHT is mostly caused by mutations either in the ENG or ACVRL1 genes, and there are regional differences in the breakdown of causative genes. The clinical presentation is also variable between populations suggesting the influence of environmental or genetic backgrounds. In this study, we report the largest series of mutational and clinical analyses for East Asians.
Methods: Using DNAs derived from peripheral blood leukocytes of 281 Japanese HHT patients from 150 families, all exons and exon-intron boundaries of the ENG, ACVRL1, and SMAD4 genes were sequenced either by Sanger sequencing or by the next-generation sequencing. Deletions/amplifications were analyzed by the multiplex ligation-dependent probe amplification analyses. Clinical information was obtained by chart review.
Results: In total, 80 and 59 pathogenic/likely pathogenic variants were identified in the ENG and ACVRL1 genes, respectively. No pathogenic variants were identified in the SMAD4 gene. In the ENG gene, the majority (60/80) of the pathogenic variants were private mutations unique to a single family, and the variants were widely distributed without any distinct hot spots. In the ACVRL1 gene, the variants were more commonly found in exons 5-10 which encompasses the serine/threonine kinase domain. Of these, 25/59 variants were unique to a single family while those in exons 8-10 tended to be shared by multiple (2-7) families. Pulmonary and cerebral AVMs were more commonly found in ENG-HHT (69.1 vs. 14.4%, 34.0 vs. 5.2%) while hepatic AVM was more common in ACVRL1-HHT (31.5 vs. 73.2%). Notable differences include an increased incidence of cerebral (34.0% in ENG-HHT and 5.2% in ACVRL1-HHT), spinal (2.5% in ENG-HHT and 1.0% in ACVL1-HHT), and gastric AVM (13.0% in ENG-HHT, 26.8% in ACVRL1-HHT) in our cohort. Intrafamilial phenotypic heterogeneity not related to the age of examination was observed in 71.4% and 24.1% of ENG- and ACVRL1-HHT, respectively.
Conclusions: In a large Japanese cohort, ENG-HHT was 1.35 times more common than ACVRL1-HHT. The phenotypic presentations were similar to the previous reports although the cerebral, spinal, and gastric AVMs were more common.
Keywords: ACVRL1; ENG; Hereditary hemorrhagic telangiectasia.
© 2021. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
Mutations in the ENG, ACVRL1, and SMAD4 genes and clinical manifestations of hereditary haemorrhagic telangiectasia: experience from the Center for Osler's Disease, Uppsala University Hospital.Ups J Med Sci. 2018 Sep;123(3):153-157. doi: 10.1080/03009734.2018.1483452. Epub 2018 Sep 25. Ups J Med Sci. 2018. PMID: 30251589 Free PMC article.
-
Clinical features and mutations in the ENG, ACVRL1, and SMAD4 genes in Korean patients with hereditary hemorrhagic telangiectasia.J Korean Med Sci. 2009 Feb;24(1):69-76. doi: 10.3346/jkms.2009.24.1.69. Epub 2009 Feb 28. J Korean Med Sci. 2009. PMID: 19270816 Free PMC article.
-
The ACVRL1 c.314-35A>G polymorphism is associated with organ vascular malformations in hereditary hemorrhagic telangiectasia patients with ENG mutations, but not in patients with ACVRL1 mutations.Am J Med Genet A. 2015 Jun;167(6):1262-7. doi: 10.1002/ajmg.a.36936. Epub 2015 Apr 2. Am J Med Genet A. 2015. PMID: 25847705 Free PMC article.
-
Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia.Expert Opin Ther Targets. 2017 Oct;21(10):933-947. doi: 10.1080/14728222.2017.1365839. Epub 2017 Aug 20. Expert Opin Ther Targets. 2017. PMID: 28796572 Review.
-
[Hereditary pulmonary hypertension family with BMPR2 gene variation: a case report and literature review].Zhonghua Jie He He Hu Xi Za Zhi. 2023 Jun 12;46(6):558-564. doi: 10.3760/cma.j.cn112147-20221123-00922. Zhonghua Jie He He Hu Xi Za Zhi. 2023. PMID: 37278169 Review. Chinese.
Cited by
-
Mutation of key signaling regulators of cerebrovascular development in vein of Galen malformations.Nat Commun. 2023 Nov 17;14(1):7452. doi: 10.1038/s41467-023-43062-z. Nat Commun. 2023. PMID: 37978175 Free PMC article.
-
Computational and Experimental Analyses for Pathogenicity Prediction of ACVRL1 Missense Variants in Hereditary Hemorrhagic Telangiectasia.J Clin Med. 2023 Jul 29;12(15):5002. doi: 10.3390/jcm12155002. J Clin Med. 2023. PMID: 37568404 Free PMC article.
-
Pharmacogenomic Considerations for Anticoagulant Prescription in Patients with Hereditary Haemorrhagic Telangiectasia.J Clin Med. 2023 Dec 15;12(24):7710. doi: 10.3390/jcm12247710. J Clin Med. 2023. PMID: 38137783 Free PMC article.
-
Pathogenic Variant Frequencies in Hereditary Haemorrhagic Telangiectasia Support Clinical Evidence of Protection from Myocardial Infarction.J Clin Med. 2023 Dec 31;13(1):250. doi: 10.3390/jcm13010250. J Clin Med. 2023. PMID: 38202257 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous